window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-ZXTT8H6EZ1');

iThera Medical reports initiation of fifth clinical site in EUPHORIA study for the non-invasive assessment of IBD

By |2022-06-22T08:41:19+01:00June 22nd, 2022|

Medical device company iThera Medical, our coordinator, announces that the fifth site has been initiated for the ongoing clinical study in the EUPHORIA project that aims to further develop the company’s proprietary optoacoustic imaging technology and demonstrate its clinical value in the assessment of inflammatory bowel disease (IBD). The EUPHORIA (Enhancing Ultrasound and PHOtoacoustics for [...]

iThera produces EUPHORIA clinical study management video

By |2022-06-13T14:09:06+01:00June 13th, 2022|

EUPHORIA Coordinator iThera Medical have released a new video to showcase the processes behind managing a multi-centre international clinical study to measure inflammation using their  MSOT technologies. The video features Claudia Jendrewski who takes us through the planning stages of preparation for the EUPHORIA clinical study protocol and recruitment processes. Watch it here. https://vimeo.com/719784005   [...]

Coordinator iThera Medical leads €1.6m project to develop machine learning-assisted optoacoustic imaging of neuromuscular disease

By |2022-05-17T20:48:34+01:00May 17th, 2022|

Congratulations to our coordinators iThera Medical who announced the kickoff of the technology innovation project SMART-3D funded by the Bavarian Research Foundation, www.forschungsstiftung.de. Commencing on May 1st, 2022, the new project aims to develop a novel, innovative approach to monitoring neuromuscular disease in pediatric patients through the company’s proprietary optoacoustic imaging technology and next-generation 3D image [...]

iThera presents at EPIC Meeting on Laser, Optics and Sensors for Medical Devices

By |2022-06-24T13:47:34+01:00April 25th, 2022|

Photonics is a key enabling technology to understand diseases, get a better diagnosis and achieve a better therapy. The EPIC Meeting on Laser, Optics and Sensors for Medical Devices at Laser World of Photonics will take place on April 28th, 2022 in Munich. The principal aim of this meeting is to discuss the current demands, [...]

iThera Medical exhibits EUPHORIA research at EMIM 2022

By |2022-03-21T14:36:45+00:00March 21st, 2022|

Last week iThera Medical, EUPHORIA's coordinators, exhibited at the 17th European Molecular Imaging Meeting,  EMIM 2022. Partners at iThera discussed the EUPHORIA clinical study with optoacoustic imaging users working with models and patients with inflammatory bowel disease (IBD). The meeting was hosted in Thessaloniki, Greece from March 15th through 18th. Browse the meeting programme and [...]

iThera Medical discusses their business goals in relation to EU-partnerships in new video

By |2021-11-25T08:40:32+00:00November 25th, 2021|

In a new video, iThera Medical CEO Christian Wiest and CCO Philipp Bell discuss their R & D strategy and primary business goals in relation to the EU-funded projects EUPHORIA and STARSTEM (www.starstem.eu, Related Project, grant number 761214). They describe the criteria and key performance indicators they use to forge and evaluate university partnerships: the organizational structures, [...]

Welcome to the EUPHORIA team, Claudia!

By |2021-10-18T08:24:19+01:00October 14th, 2021|

Claudia Jendrewski One hallmark of success is to see the size of the workforce at iThera Medical growing. One such recent addition has joined the team of researchers on the EUPHORIA project. We welcome Claudia Jendrewski, who joined ITM in October 2021 as a Clinical Trial Manager. Claudia is leading iThera-sponsored clinical investigations. [...]

Partner News: iThera Medical introduces the world’s first transmission ultrasound system

By |2021-10-07T15:03:20+01:00October 7th, 2021|

Today, EUPHORIA Coordinators iThera Medical announced the launch of its new inVision TRIO preclinical optoacoustic imaging system. The inVision TRIO is the first imaging system in the world that incorporates transmission ultrasound computed tomography (TUCT) and expands the field of biomedical applications addressable using iThera Medical’s optoacoustic imaging systems. The new inVision TRIO offers tremendous flexibility [...]

PRESS RELEASE: iThera Medical reports initiation of second site in ongoing clinical study for the non-invasive assessment of inflammatory bowel disease

By |2021-09-23T14:52:54+01:00September 23rd, 2021|

Medical device company iThera Medical announces that the second site in Germany has been initiated for the ongoing clinical study in the EU-funded Horizon 2020 project EUPHORIA. The project aims to further develop the company’s proprietary optoacoustic imaging technology and demonstrate its clinical value in the assessment of inflammatory bowel disease (IBD). The €2.3 million [...]

iThera leads €1.9m research project to advance optoacoustic imaging technology towards AI-supported quantitative medical diagnosis

By |2021-09-13T15:12:27+01:00September 13th, 2021|

EUPHORIA Coordinators, iThera Medical GmbH has received grant funding from the Bavarian Ministry of Economic Affairs, Regional Development and Energy to conduct a Euro 1.9 million R&D project to develop next-generation AI-supported electronics for its MSOT imaging systems for inflammatory bowel disease. The Bavarian state-funded technology innovation project, DeepOPUS, launched today, September 13th, 2021, aims to augment [...]

Go to Top